About
Oncology Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
98
By Phase
PHASE1/PHASE2: 2PHASE2: 2
By Status
COMPLETED: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06616389Lead Sponsor
Study of ODX (OsteoDex) in Multiple Myeloma
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 29, 2023 · Completed: Jan 30, 2026
NCT02825628Lead Sponsor
Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
PHASE2Completed
55 participants
Started: May 31, 2016 · Completed: Jun 30, 2020
NCT02378870Lead Sponsor
A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC
PHASE2Terminated
3 participants
Started: Jan 31, 2015 · Completed: Sep 30, 2015
NCT01595087Lead Sponsor
A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
PHASE1/PHASE2Completed
28 participants
Started: Jan 31, 2012 · Completed: Sep 30, 2013
Locations (1)
Headquarters
Uppsala, Sweden
Map
Loading map...